Preclinical Evaluation of a Protein-Based Nanoscale Contrast Agent for MR Angiography at an Ultralow Dose

Preclinical Evaluation of a Protein-Based Nanoscale Contrast Agent for MR Angiography at an Ultralow Dose

Jianmin Li,1,2,* Wenyi Zhang,1,2,* Shuang Liu,1,2,* Fan Yang,2 Yupeng Zhou,2 Lin Cao,1,2 Yiming Li,1,2 Yunfei Guo,1,2 Xiang Qi,1,2 Guoping Xu,1 Jing Peng,1 Yang Zhao1,2 1Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Li J, Zhang W, Liu S, Yang F, Zhou Y, Cao L, Li Y, Guo Y, Qi X, Xu G, Peng J, Zhao Y
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:International Journal of Nanomedicine
Subjects:
preclinical evaluation
ultralow dose
high-pressure injector
mr angiography
Online Access:https://www.dovepress.com/preclinical-evaluation-of-a-protein-based-nanoscale-contrast-agent-for-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/preclinical-evaluation-of-a-protein-based-nanoscale-contrast-agent-for-peer-reviewed-fulltext-article-IJN

Similar Items